New policy on conflict of interest

The NHMRC said it hoped the new policy, released last week, would become a world benchmark in ensuring clinical advice was not tainted.

The council was accused of lacking scientific rigour when the American author of draft guidelines on ADHD failed to declare ties with pharmaceutical companies.

But Professor John McCallum, head of research translation at NHMRC, said the new approach was not instigated as a direct result of this controversy. He said: “This is more about sensitivity to public interest.”